litlas
Log inCreate account

William L. Gerald

Active 1989–2013

138
Papers
52,301
Citations
109
h-index
138
i10-index

Citations

Citations per year for William L. Gerald1926: 2 citations1976: 1 citations1986: 1 citations1990: 1 citations1991: 5 citations1992: 6 citations1993: 16 citations1994: 12 citations1995: 33 citations1996: 64 citations1997: 65 citations1998: 102 citations1999: 96 citations2000: 182 citations2001: 226 citations2002: 266 citations2003: 284 citations2004: 320 citations2005: 406 citations2006: 487 citations2007: 532 citations2008: 695 citations2009: 820 citations2010: 893 citations2011: 1,018 citations2012: 919 citations2013: 941 citations2014: 817 citations2015: 739 citations2016: 605 citations2017: 524 citations2018: 492 citations2019: 1,389 citations2020: 1,305 citations2021: 1,171 citations2022: 731 citations2023: 517 citations2024: 606 citations2025: 284 citations2026: 4 citations1927–1975: no citations, so these years are not shown1977–1985: no citations, so these years are not shown1987–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,562 citing papers, 34.6% of this breakdownChina: 2,354 citing papers, 10.8% of this breakdownUnited Kingdom: 1,266 citing papers, 5.8% of this breakdownGermany: 957 citing papers, 4.4% of this breakdownCanada: 825 citing papers, 3.8% of this breakdownItaly: 815 citing papers, 3.7% of this breakdownJapan: 750 citing papers, 3.4% of this breakdownFrance: 699 citing papers, 3.2% of this breakdownAustralia: 600 citing papers, 2.7% of this breakdownSpain: 560 citing papers, 2.6% of this breakdownNetherlands: 491 citing papers, 2.2% of this breakdownSouth Korea: 423 citing papers, 1.9% of this breakdown
0%34.6%Other 20.9%

Institutions

Fields

  • Medicine46.7%
  • Biochemistry, Genetics and Molecular Biology45.6%
  • Immunology and Microbiology3%
  • Computer Science1.5%
  • Neuroscience1%
  • Engineering0.6%
  • Other1.6%

Topics

  • Prostate Cancer Treatment and Research3.7%
  • Cancer Cells and Metastasis2.9%
  • MicroRNA in disease regulation2.4%
  • Epigenetics and DNA Methylation2.3%
  • Lung Cancer Treatments and Mutations2.3%
  • Cancer-related molecular mechanisms research2.2%
  • Other84.2%

Coauthors

All papers

Open in search
  1. Integrative Genomic Profiling of Human Prostate Cancer

    Authors: Barry S. Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S. Carver, Vivek Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva, Yevgeniy Antipin, Nicholas Mitsiades, Thomas Landers, Igor Dolgalev, John E. Major, Manda Wilson, Nicholas D. Socci, Alex Lash, Adriana Heguy, James A. Eastham, Howard I. Scher, Victor E. Reuter, Peter T. Scardino, Chris Sander, Charles L. Sawyers, William L. Gerald - Cancer Cell 2010 cited by 3,792

  2. Genes that mediate breast cancer metastasis to lung

    Authors: Andy J. Minn, Gaorav P. Gupta, Peter M. Siegel, Paula D. Bos, Weiping Shu, Dilip D. Giri, Agnès Viale, Adam B. Olshen, William L. Gerald, Joan Massagué - Nature 2005 cited by 2,975

  3. Genes that mediate breast cancer metastasis to the brain

    Authors: Paula D. Bos, Xiang H.-F. Zhang, Cristina Nadal, Weiping Shu, Roger R. Gomis, Don X. Nguyen, Andy J. Minn, Marc J. van de Vijver, William L. Gerald, John A. Foekens, Joan Massagué - Nature 2009 cited by 1,905

  4. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

    Authors: Zhenbang Chen, Lloyd C. Trotman, David R. Shaffer, Hui‐Kuan Lin, Zohar Dotan, Masaru Niki, Jason A. Koutcher, Howard I. Scher, Thomas Ludwig, William L. Gerald, Carlos Cordon‐Cardo, Pier Paolo Pandolfi - Nature 2005 cited by 1,986

  5. TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4

    Authors: David Padua, Xiang H.-F. Zhang, Qiongqing Wang, Cristina Nadal, William L. Gerald, Roger R. Gomis, Joan Massagué - Cell 2008 cited by 943

  6. Multiclass cancer diagnosis using tumor gene expression signatures

    Authors: Sridhar Ramaswamy, Pablo Tamayo, Ryan Rifkin, Sayan Mukherjee, Chen-Hsiang Yeang, Michael Angelo, Christine Ladd, Michael Reich, Éva Latulippe, Jill P. Mesirov, Tomaso Poggio, William L. Gerald, Massimo Loda, Eric S. Lander, Todd R. Golub - National Academy of Sciences, Proceedings of the National Academy of Sciences 2001 cited by 2,046

  7. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

    Authors: James Bean, Cameron Brennan, Jin‐Yuan Shih, Gregory J. Riely, Agnès Viale, Lu Wang, Dhananjay Chitale, Noriko Motoi, János Szőke, Stephen Broderick, Marissa N. Balak, W.C. Chang, Chong‐Jen Yu, Adi F. Gazdar, Harvey I. Pass, Valerie W. Rusch, William L. Gerald, Shiu‐Feng Huang, Pan‐Chyr Yang, Vincent A. Miller, Marc Ladanyi, Chih-Hsin Yang, William Pao - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 1,586

  8. Endogenous human microRNAs that suppress breast cancer metastasis

    Authors: Sohail F. Tavazoie, Claudio R. Alarcón, Thórdur Óskarsson, David Padua, Qiongqing Wang, Paula D. Bos, William L. Gerald, Joan Massagué - Nature 2008 cited by 1,859

  9. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

    Authors: Kerby Shedden, David G. Beer, Kerby Shedden, Rork Kuick, Samir Hanash, Andrew C. Chang, Jeremy M. G. Taylor, David E. Misek, Jeremy M. G. Taylor, Steven A. Eschrich, Michael E. Gruidl, Steven A. Enkemann, Anupama Sharma, Timothy J. Yeatman, Chang‐Qi Zhu, Frances A. Shepherd, Daniel Strumpf, Igor Jurišica, Janos Szoke, János Szőke, Noriko Motoi, Mark G. Kris, Valerie W. Rusch, Agnès Viale, William L. Gerald, Maureen F. Zakowski, William D. Travis, Thomas J. Giordano, David E. Misek, Andrew C. Chang, David G. Beer, Keyue Ding, Lesley Seymour, Nathan A. Pennell, Matthew Meyerson, Katsuhiko Naoki, Barbara A. Weir, Kevin K Dobbin, Christine Ladd‐Acosta, Todd R. Golub - Nature Medicine 2008 cited by 1,243

  10. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

    Authors: Akihiko Yoshizawa, Noriko Motoi, Gregory J. Riely, Cami S. Sima, William L. Gerald, Mark G. Kris, Bernard J. Park, Valerie W. Rusch, William D. Travis - Modern Pathology 2011 cited by 994

  11. Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals

    Authors: Xiang H.-F. Zhang, Qiongqing Wang, William L. Gerald, Clifford A. Hudis, Larry Norton, Marcel Smid, John A. Foekens, Joan Massagué - Cancer Cell 2009 cited by 658

  12. Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

    Authors: Michal Sheffer, Manny D. Bacolod, Or Zuk, Sarah F. Giardina, Hanna Pinças, Francis Barany, Philip B. Paty, William L. Gerald, Daniel A. Notterman, Eytan Domany - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 419

  13. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors

    Authors: Andy J. Minn, Yibin Kang, Inna Serganova, Gaorav P. Gupta, Dilip D. Giri, Mikhail Doubrovin, Vladimir Ponomarev, William L. Gerald, Ronald G. Blasberg, Joan Massagué - Journal of Clinical Investigation 2005 cited by 693

  14. WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis

    Authors: Don X. Nguyen, Anne C. Chiang, Xiang H.-F. Zhang, Juliet Y. Kim, Mark G. Kris, Marc Ladanyi, William L. Gerald, Joan Massagué - Cell 2009 cited by 633

  15. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate

    Authors: Brett S. Carver, Jennifer Tran, Anuradha Gopalan, Zhenbang Chen, Safa Shaikh, Arkaitz Carracedo, Andrea Alimonti, Caterina Nardella, Shohreh Varmeh, Peter T. Scardino, Carlos Cordon‐Cardo, William L. Gerald, Pier Paolo Pandolfi - Nature Genetics 2009 cited by 661

  16. EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations

    Authors: Rohit Bhargava, William L. Gerald, Allan R. Li, Qiulu Pan, Priti Lal, Marc Ladanyi, Beiyun Chen - Modern Pathology 2005 cited by 356

  17. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

    Authors: Sizhi Paul Gao, Kevin G. Mark, Kenneth Leslie, William Pao, Noriko Motoi, William L. Gerald, William D. Travis, William G. Bornmann, Darren R. Veach, Bayard Clarkson, Jacqueline Bromberg - Journal of Clinical Investigation 2007 cited by 664

  18. PIK3CA Mutation Associates with Improved Outcome in Breast Cancer

    Authors: Kevin Kalinsky, Lindsay M. Jacks, Adriana Heguy, Sujata Patil, Marija Drobnjak, Umesh Bhanot, Cyrus V. Hedvat, Tiffany A. Traina, David B. Solit, William L. Gerald, Mary Ellen Moynahan - Clinical Cancer Research 2009 cited by 416

  19. Cyclin D1 Is Transcriptionally Regulated by and Required for Transformation by Activated Signal Transducer and Activator of Transcription 3

    Authors: Kenneth Leslie, Cynthia Lang, Geeta Devgan, Janeen Azare, Marjan Berishaj, William L. Gerald, Young Bae Kim, Keren Paz, James Darnell, Christopher Albanese, Toshiyuki Sakamaki, Richard G. Pestell, Jacqueline Bromberg - Cancer Research 2006 cited by 282

  20. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway

    Authors: Yibin Kang, Wei He, Shaun Tulley, Gaorav P. Gupta, Inna Serganova, Chang-Rung Chen, Katia Manova‐Todorova, Ronald G. Blasberg, William L. Gerald, Joan Massagué - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 cited by 533

  21. An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

    Authors: Ashley S. Doane, Michael A. Danso, Priti Lal, M. Donaton, L Zhang, Clifford A. Hudis, William L. Gerald - Oncogene 2006 cited by 601

  22. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

    Authors: Eva Hernando, Zaher Nahlé, Gloria Juan, Elena Dı́az-Rodrı́guez, Miguel Alaminos, Michael T. Hemann, Loren S. Michel, Vivek Mittal, William L. Gerald, Robert Benezra, Scott W. Lowe, Carlos Cordon‐Cardo - Nature 2004 cited by 563

  23. NF-κB Regulates Androgen Receptor Expression and Prostate Cancer Growth

    Authors: Liying Zhang, Saleh Altuwaijri, Fang‐Ming Deng, Lishi Chen, Priti Lal, Umesh Bhanot, Ruslan Korets, Sven Wenske, Hans Lilja, Chawnshang Chang, Howard I. Scher, William L. Gerald - American Journal Of Pathology 2009 cited by 191

  24. The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers

    Authors: Selvaraju Veeriah, Cameron Brennan, Shasha Meng, Bhuvanesh Singh, James A. Fagin, David B. Solit, Philip B. Paty, Dan Rohle, Igor Vivanco, Juliann Chmielecki, William Pao, Marc Ladanyi, William L. Gerald, Linda M. Liau, Timothy C. Cloughesy, Paul S. Mischel, Chris Sander, Barry S. Taylor, Nikolaus Schultz, John E. Major, Adriana Heguy, Fang Fang, Ingo K. Mellinghoff, Timothy A. Chan - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 321